Moreover, this engineered probiotic can consume lactate in tumor cells from the inside out, effectively reduce the expression of PD‐L1 and inhibit the activation of the AKT‐mTOR metabolic pathway, thereby synergizing lactate metabolism‐immunity‐enzyme dynamic therapy to effectively inhibit tumor development. This evidence concerns the gene AKT1 and neoplasm.